(Q41666081)

6 October 2017

title

Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder (English)

1 reference

borderline personality disorder

6 October 2017

main subject

0 references

1 reference

O C Pinto

1

1 reference

6 October 2017

H S Akiskal

series ordinal

2

1 reference

6 October 2017

publication date

1 December 1998

1 reference

Journal of Affective Disorders

6 October 2017

published in

1 reference

6 October 2017

volume

51

1 reference

6 October 2017

issue

3

1 reference

6 October 2017

page(s)

333-343

1 reference

Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Subaffective Disorders: Dysthymic, Cyclothymic and Bipolar II Disorders in the “;Borderline” Realm

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

The nosologic status of borderline personality: clinical and polysomnographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

The temperamental borders of affective disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Comparison of borderline personality subcategories to schizophrenic and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

The emerging epidemiology of hypomania and bipolar II disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

An affective syndrome in psychopaths with borderline personality disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Symptoms and EEG findings in the borderline syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

The Relationship of Affective Illness and Personality Disorders in Psychiatric Outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Auditory evoked potentials in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Soft sign neurological abnormalities in borderline personality disorder and normal control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Self-ratings of anger and hostility in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

A current view of the interface between borderline personality disorder and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Affective instability and impulsivity in personality disorder. Results of an experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

An open study of lamotrigine in refractory bipolar depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Antidepressant-associated mania: a study of anxiety disorders patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Allergic skin rash with lamotrigine and concomitant valproate therapy: evidence for an increased risk

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Safety of long-term lamotrigine in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Fluoxetine in the treatment of borderline and schizotypal personality disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Safety review of adult clinical trial experience with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Fluoxetine in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

The high prevalence of "soft" bipolar (II) features in atypical depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Identifying the depressive border of the borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Electroencephalography of DSM-III borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Characterizing anger in the DSM-III borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Efficacy of phenelzine and haloperidol in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Affect instability in adults with a borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Neuropsychological function in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

Divalproex sodium as a treatment for borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900007-5

7 January 2021

10.1016/S0165-0327(99)00007-5

Identifiers

DOI

1 reference

6 October 2017

1 reference